• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调强放疗后鼻咽癌淋巴结坏死的预后价值和分期分类。

Prognostic Value and Staging Classification of Lymph Nodal Necrosis in Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy.

机构信息

Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou, China.

出版信息

Cancer Res Treat. 2019 Jul;51(3):1222-1230. doi: 10.4143/crt.2018.595. Epub 2018 Dec 27.

DOI:10.4143/crt.2018.595
PMID:30590003
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6639214/
Abstract

PURPOSE

The aim of the present study was to evaluate the prognostic value of magnetic resonance imaging (MRI)‒determined lymph nodal necrosis (LNN) in nasopharyngeal carcinoma (NPC) and explore the feasibility of an N-classification system based on the 8th edition of the American Joint Committee on Cancer (AJCC) system.

MATERIALS AND METHODS

The MRI scans of 616 patients with newly diagnosed stage T1-4N1-3M0 NPC who were treated with definitive intensity-modulated radiotherapy (IMRT) were reviewed.

RESULTS

Multivariate analysis showed that LNN was an independent negative prognostic predictor of distant metastasis free survival (hazard ratio, 1.634; 95% confidence interval, 1.023 to 2.609; p=0.040) and overall survival (hazard ratio, 2.154; 95% confidence interval, 1.282 to 3.620; p=0.004). Patients of classification N1 disease with LNN were reclassified as classification N2, and classification N2 disease with LNN as classification N3 in the proposed N-classification system. Correlation with death and distant failure was significant, and the total difference between N1 and N3 was wider with the proposed system.

CONCLUSION

MRI-determined LNN is an independent negative prognostic factor for NPC. The proposed N classification system is powerfully predictive.

摘要

目的

本研究旨在评估磁共振成像(MRI)确定的淋巴结坏死(LNN)在鼻咽癌(NPC)中的预后价值,并探讨基于第 8 版美国癌症联合委员会(AJCC)系统的 N 分类系统的可行性。

材料与方法

回顾了 616 例接受根治性调强放疗(IMRT)治疗的初诊 T1-4N1-3M0 NPC 患者的 MRI 扫描。

结果

多因素分析显示,LNN 是远处无转移生存(风险比,1.634;95%置信区间,1.023 至 2.609;p=0.040)和总生存(风险比,2.154;95%置信区间,1.282 至 3.620;p=0.004)的独立负预后预测因子。在提出的 N 分类系统中,N1 疾病伴有 LNN 的患者被重新分类为 N2,N2 疾病伴有 LNN 的患者被重新分类为 N3。与死亡和远处失败的相关性显著,且与新系统相比,N1 和 N3 之间的总差异更大。

结论

MRI 确定的 LNN 是 NPC 的独立负预后因素。提出的 N 分类系统具有较强的预测能力。

相似文献

1
Prognostic Value and Staging Classification of Lymph Nodal Necrosis in Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy.调强放疗后鼻咽癌淋巴结坏死的预后价值和分期分类。
Cancer Res Treat. 2019 Jul;51(3):1222-1230. doi: 10.4143/crt.2018.595. Epub 2018 Dec 27.
2
Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.比较 UICC/AJCC 第七版和第八版鼻咽癌分期系统:两个中心 1317 例调强放疗患者的分析。
BMC Cancer. 2018 May 29;18(1):606. doi: 10.1186/s12885-018-4419-1.
3
Nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: clinical outcomes and patterns of failure among subsets of 8th AJCC stage IVa.调强放疗治疗鼻咽癌:8 期 AJCC 分期 IVa 亚组的临床结果和失败模式。
Eur Radiol. 2020 Feb;30(2):816-822. doi: 10.1007/s00330-019-06500-5. Epub 2019 Oct 24.
4
Suggestions for lymph node classification of UICC/AJCC staging system: a retrospective study based on 1197 nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy.国际抗癌联盟(UICC)/美国癌症联合委员会(AJCC)分期系统中淋巴结分类的建议:一项基于1197例接受调强放射治疗的鼻咽癌患者的回顾性研究。
Medicine (Baltimore). 2015 May;94(20):e808. doi: 10.1097/MD.0000000000000808.
5
Added value of metastatic cervical lymph node group V in nodal staging of nasopharyngeal cancer.鼻咽癌颈淋巴结Ⅴ组转移在淋巴结分期中的附加价值
Head Neck. 2020 Oct;42(10):2801-2810. doi: 10.1002/hed.26325. Epub 2020 Jun 16.
6
Proposed lymph node staging system using the International Consensus Guidelines for lymph node levels is predictive for nasopharyngeal carcinoma patients from endemic areas treated with intensity modulated radiation therapy.采用国际共识指南的淋巴结分期系统预测了接受调强放疗的来自鼻咽癌高发区的患者的淋巴结状况。
Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):249-56. doi: 10.1016/j.ijrobp.2012.09.003. Epub 2012 Nov 29.
7
Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system.根据第七版 AJCC 分期系统,调强放疗治疗 N0 期鼻咽癌患者的治疗效果令人鼓舞。
BMC Cancer. 2012 Feb 15;12:68. doi: 10.1186/1471-2407-12-68.
8
Prognosis and staging of parotid lymph node metastasis in nasopharyngeal carcinoma: An analysis in 10,126 patients.鼻咽癌腮腺淋巴结转移的预后和分期:10126 例患者分析。
Oral Oncol. 2019 Aug;95:150-156. doi: 10.1016/j.oraloncology.2019.06.013. Epub 2019 Jun 22.
9
Impact of intensity-modulated radiotherapy on nasopharyngeal carcinoma: Validation of the 7th edition AJCC staging system.调强放射治疗对鼻咽癌的影响:美国癌症联合委员会(AJCC)第7版分期系统的验证
Oral Oncol. 2015 Mar;51(3):254-9. doi: 10.1016/j.oraloncology.2014.10.012. Epub 2014 Nov 6.
10
Prognostic value and staging classification of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.调强放疗治疗鼻咽癌患者咽后淋巴结转移的预后价值及分期分类
PLoS One. 2014 Oct 10;9(10):e108375. doi: 10.1371/journal.pone.0108375. eCollection 2014.

引用本文的文献

1
Advances in Nasopharyngeal Carcinoma Staging: from the 7th to the 9th Edition of the TNM System and Future Outlook.鼻咽癌分期的进展:从第7版到第9版TNM系统及未来展望
Curr Oncol Rep. 2025 Mar;27(3):322-332. doi: 10.1007/s11912-025-01651-9. Epub 2025 Feb 25.
2
Advanced image-identified extranodal extension of retropharyngeal lymph nodes in the refinement of N classification for nasopharyngeal carcinoma.在鼻咽癌N分期细化中,利用高级图像识别技术确定咽后淋巴结的结外侵犯情况
Cell Rep Med. 2025 Feb 18;6(2):101942. doi: 10.1016/j.xcrm.2025.101942. Epub 2025 Feb 11.
3
The Prognostic Value of Serum Sialic Acid in Patients with Nasopharyngeal Carcinoma: A Propensity Score Matching Study.

本文引用的文献

1
Cisplatin and Fluorouracil Induction Chemotherapy With or Without Docetaxel in Locoregionally Advanced Nasopharyngeal Carcinoma.顺铂和氟尿嘧啶诱导化疗联合或不联合多西他赛用于局部晚期鼻咽癌的治疗
Transl Oncol. 2019 Apr;12(4):633-639. doi: 10.1016/j.tranon.2019.01.002. Epub 2019 Feb 20.
2
Paranasal Sinus Invasion in Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy.调强放疗后鼻咽癌的鼻窦侵犯。
Cancer Res Treat. 2019 Jan;51(1):73-79. doi: 10.4143/crt.2017.607. Epub 2018 Feb 26.
3
Influence of Cervical Node Necrosis of Different Grades on the Prognosis of Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiotherapy.
血清唾液酸在鼻咽癌患者中的预后价值:一项倾向评分匹配研究
Cancer Manag Res. 2024 Mar 20;16:215-224. doi: 10.2147/CMAR.S448238. eCollection 2024.
4
Prognostic Value of Lymph Node Necrosis at Different N Stages in Patients with Nasopharyngeal Carcinoma.鼻咽癌患者不同N分期时淋巴结坏死的预后价值
J Cancer. 2023 Jul 9;14(11):2085-2092. doi: 10.7150/jca.84854. eCollection 2023.
5
Intra- and peritumoral MRI radiomics assisted in predicting radiochemotherapy response in metastatic cervical lymph nodes of nasopharyngeal cancer.MRI 影像组学分析肿瘤内及肿瘤周围特征有助于预测鼻咽癌转移性颈部淋巴结放化疗疗效。
BMC Med Imaging. 2023 May 30;23(1):66. doi: 10.1186/s12880-023-01026-1.
6
FMISO-Based Adaptive Radiotherapy in Head and Neck Cancer.基于氟代脱氧吗啉硝唑的头颈部癌自适应放疗
J Pers Med. 2022 Jul 29;12(8):1245. doi: 10.3390/jpm12081245.
7
Efficacy of concurrent chemoradiotherapy plus Endostar compared with concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study.恩度联合放化疗对比单纯放化疗治疗局部晚期鼻咽癌的疗效:一项回顾性研究。
Radiat Oncol. 2022 Jul 29;17(1):135. doi: 10.1186/s13014-022-02104-4.
8
Prognostic value of cervical nodal necrosis on staging imaging of nasopharyngeal carcinoma in era of intensity-modulated radiotherapy: a systematic review and meta-analysis.调强放疗时代鼻咽癌分期影像学中颈淋巴结坏死的预后价值:系统评价和荟萃分析。
Cancer Imaging. 2022 May 20;22(1):24. doi: 10.1186/s40644-022-00462-6.
9
A nonendemic analysis of the patterns and prognosis of de novo metastatic nasopharyngeal carcinomas in older patients aged ≥ 65 years.≥65 岁老年初发转移性鼻咽癌的非流行性病分析模式和预后。
Sci Rep. 2022 May 18;12(1):8321. doi: 10.1038/s41598-022-12368-1.
10
Prognostic Factors for Overall Survival in Nasopharyngeal Cancer and Implication for TNM Staging by UICC: A Systematic Review of the Literature.鼻咽癌总生存的预后因素及国际抗癌联盟(UICC)TNM分期的意义:文献系统综述
Front Oncol. 2021 Sep 2;11:703995. doi: 10.3389/fonc.2021.703995. eCollection 2021.
不同分级的颈部淋巴结坏死对接受调强放疗的鼻咽癌患者预后的影响
J Cancer. 2017 Mar 12;8(6):959-966. doi: 10.7150/jca.17998. eCollection 2017.
4
Radiomics Features of Multiparametric MRI as Novel Prognostic Factors in Advanced Nasopharyngeal Carcinoma.多参数 MRI 放射组学特征作为晚期鼻咽癌的新型预后因素。
Clin Cancer Res. 2017 Aug 1;23(15):4259-4269. doi: 10.1158/1078-0432.CCR-16-2910. Epub 2017 Mar 9.
5
Nasopharyngeal carcinoma.鼻咽癌。
Lancet. 2016 Mar 5;387(10022):1012-1024. doi: 10.1016/S0140-6736(15)00055-0. Epub 2015 Aug 28.
6
Prognostic Value of Cervical Nodal Necrosis in Nasopharyngeal Carcinoma: Analysis of 1800 Patients with Positive Cervical Nodal Metastasis at MR Imaging.鼻咽癌颈部淋巴结坏死的预后价值:1800例颈部淋巴结转移阳性患者的磁共振成像分析
Radiology. 2015 Aug;276(2):619. doi: 10.1148/radiol.15154020.
7
Update report of T4 classification nasopharyngeal carcinoma after intensity-modulated radiotherapy: an analysis of survival and treatment toxicities.调强放疗后T4期鼻咽癌的更新报告:生存及治疗毒性分析
Oral Oncol. 2015 Feb;51(2):190-4. doi: 10.1016/j.oraloncology.2014.11.009. Epub 2014 Nov 26.
8
Prognostic value and staging classification of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.调强放疗治疗鼻咽癌患者咽后淋巴结转移的预后价值及分期分类
PLoS One. 2014 Oct 10;9(10):e108375. doi: 10.1371/journal.pone.0108375. eCollection 2014.
9
Evolution of treatment for nasopharyngeal cancer--success and setback in the intensity-modulated radiotherapy era.鼻咽癌治疗的演进——调强放射治疗时代的成功与挫折
Radiother Oncol. 2014 Mar;110(3):377-84. doi: 10.1016/j.radonc.2014.02.003. Epub 2014 Mar 11.
10
Update report of nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy and hypothesis of the optimal margin.鼻咽癌缩野调强放射治疗的最新报告及最佳边界假设
Radiother Oncol. 2014 Mar;110(3):385-9. doi: 10.1016/j.radonc.2014.01.011. Epub 2014 Feb 20.